July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing

What it is about

Who published it, and when

How it spread - 3 original reports

1. Fri, 7 August 2026

   1 report
   • clinicalleader.com05:15first to report
     July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing

     Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.

2. Sun, 9 August 2026

   1 report
   • livemint.com06:00
     How Trump's tariffs are reshaping Indian pharma

     US tariffs may not impact Indian pharma in the short term, but building replacement capacity on US soil remains cost-prohibitive for thin-margin producers. At the same time, a Deloitte survey reveals CXOs want to prioritize specialty expansion.

3. Wed, 12 August 2026

   1 report
   • South China Morning Post11:40
     Will Trump’s proposed drug tariffs end India’s reign as ‘pharmacy of the world’?

     India’s long-held status as the “pharmacy of the world” could be affected by US President Donald Trump’s plan to impose steep tariffs on imported drugs from 2028, threatening the low-cost, export-driven model that has made the country a vital supplier of generic medicines, analysts have warned. Late last month, Trump announced that the US would impose 100 per cent tariffs on generic medicines from August 2028 and increase them to 200 per cent after one year, signalling a major push to bring...